Skip to main content

Advertisement

SpringerLink
Log in

Chronic daily headache: Transformational migraine, chronic migraine, and related disorders

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Chronic daily headache is an important category of headache illness that affects 4% of the general population. Within this classification are four chronic headache entities: chronic migraine/transformational migraine, chronic tension-type headache, hemicrania continua, and new daily persistent headache. Chronic migraine/transformational migraine is the most common of these entities and is frequently accompanied by medication overuse, neurobehavioral comorbidity, and disability. The terminology and classification of this entity continue to be confounding. Current research is directed at identifying factors that might promote the progression of this disorder from episodic migraine to daily or almost daily headache, and at identifying the best approaches to treatment, which include both pharmacotherapeutic and non-medicinal interventions. Patients with intractable cases are often hospitalized as a consequence of the convergence of several factors that make outpatient management unlikely to succeed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Silberstein SD, Lipton RB, Dodick DW (editors): Wolff’s Headache and Other Pain, edn 8. New York: Oxford University Press; 2008.

    Google Scholar 

  2. Scher AL, Stewart WF, Liberman J, Lipton RB: Prevalence of frequent headache in a population sample. Headache 1998, 38:497–506.

    Article  PubMed  CAS  Google Scholar 

  3. Wang SJ, Fuh JL, Lu SR, et al.: Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000, 54:314–319.

    PubMed  CAS  Google Scholar 

  4. Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004, 24(Suppl 1):9–160.

    Google Scholar 

  5. Mathew NT, Stubits E, Nigam MP: Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982, 22:66–68.

    Article  PubMed  CAS  Google Scholar 

  6. Saper JR, VanMeter MJ: Ergotamine addiction [abstract]. Presented at the American Association for the Study of Headache. San Francisco, CA; June, 1980.

  7. Saper JR, Winters M, VanMeter MJ: Non-headache features of cluster headache [abstract]. Presented at the American Association for the Study of Headache. Washington, DC; June, 1981.

  8. Saper JR: Headache Disorders: Current Concepts and Treatment Strategies. Boston: J. Wright-PSG Medical Publishers; 1983.

    Google Scholar 

  9. Silberstein SD, Lipton RB, Solomon S, Mathew NT: Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 1994, 34:1–7.

    Article  Google Scholar 

  10. Saper JR, Jones JM: Ergotamine tartrate dependency: features and possible mechanisms. Clin J Neuropharmacol 1986, 9:244–256.

    Article  CAS  Google Scholar 

  11. Headache Classification Committee: The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2006, 26:742–746.

    Article  Google Scholar 

  12. Saper JR, Silberstein SD, Gordon CD, Hamel RL: Handbook of Headache Management, edn 2. Baltimore: Lippincott, Williams & Wilkins; 1999.

    Google Scholar 

  13. Saper JR, Dodick D, Gladstone JP: Management of chronic daily headache: challenges in clinical practice. Headache 2005, 45(Suppl 1):S74–S85.

    Article  PubMed  Google Scholar 

  14. Saper JR: Approach to the intractable headache case: identifying treatable barriers to improvement. Continuum: Lifelong Learning in Neurology 2006, 12:259–284.

    Google Scholar 

  15. Merikangas KR, Angst J, Isler H: Migraine and psychopathology: results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990, 47:849–853.

    PubMed  CAS  Google Scholar 

  16. Breslau N, Davis GC: Migraine, physical health, and psychiatric disorders: a prospective epidemiologic study of young adults. J Psychiatric Res 1993, 27:211–221.

    Article  CAS  Google Scholar 

  17. Mathew NT: Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 1981, 21:105–109.

    Article  PubMed  CAS  Google Scholar 

  18. Mongini F, Defilippi N, Negro C: Chronic daily headache. A clinical and psychologic profile before and after treatment. Headache 1997, 37:83–87.

    Article  PubMed  CAS  Google Scholar 

  19. Lake AE, Saper JR, Hamel RL: Inpatient treatment of intractable headache: outcome for 267 consecutive program completers [abstract]. Headache 2006, 46:893.

    Google Scholar 

  20. Peres MF, Silberstein SD, Nahmias S, et al.: Hemicrania continua is not that rare. Neurology 2001, 57:948–951.

    PubMed  CAS  Google Scholar 

  21. Granella F, Cavallini A, Sandrini G, et al.: Long-term outcome of migraine. Cephalalgia 1998, 18:30–33.

    PubMed  Google Scholar 

  22. Scher AI, Lipton RB, Stewart W: Risk factors for chronic daily headache. Curr Pain Headache Rep 2002, 6:486–491.

    Article  PubMed  Google Scholar 

  23. Scher AI, Stewart WF, Ricci JA, Lipton RB: Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003, 106:81–89.

    Article  PubMed  CAS  Google Scholar 

  24. Bigal ME, Sheftell FD, Rapoport AM, et al.: Chronic daily headache: identification of factors associated with induction and transformation. Headache 2002, 42:575–581.

    Article  PubMed  Google Scholar 

  25. Burstein R: Deconstructing migraine headache into a peripheral and central sensitization. Pain 2001, 89:107–110.

    Article  PubMed  CAS  Google Scholar 

  26. Watkins LR, Milligan ED, Maier SF: Glial activation: a driving force for pathological pain. Trends Neurosci 2001, 24:450–455.

    Article  PubMed  CAS  Google Scholar 

  27. Meng ID, Porreca F: Headache currents. Basic Science: mechanisms of medication overuse. Headache 2004, 1:47–54.

    Article  Google Scholar 

  28. Mao J, Sung B, Ji RR, et al.: Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 2002, 22:7650–7661.

    PubMed  CAS  Google Scholar 

  29. Saper JR, Hamel RL, Lake AE III: Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005, 25:545–546.

    Article  PubMed  CAS  Google Scholar 

  30. Schwedt TJ, Dodick DW, Trentman TL, et al.: Occipital nerve stimulation for chronic cluster headache and hemicrania continua: pain relief and persistence of autonomic features. Cephalalgia 2006, 26:1025–1027.

    Article  PubMed  CAS  Google Scholar 

  31. Lim G, Wang S, Zeng Q, et al.: Evidence for long-term influence on morphine tolerance after previous morphine exposure: role of glucocorticoid receptors. Pain 2005, 114:81–92.

    Article  PubMed  CAS  Google Scholar 

  32. Saper JR, Lake AE III: Medication overuse headache: type I and type II [letter]. Cephalalgia 2006, 26:1262.

    Article  PubMed  CAS  Google Scholar 

  33. Ozyalcin SN, Talu GK, Kizitan E, et al.: The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005, 45:144–152.

    Article  PubMed  Google Scholar 

  34. Jensen R, Brinck T, Olesen J: Sodium valproate has a prophylactic effect in migraine without aura. Neurology 1994, 44:647–651.

    PubMed  CAS  Google Scholar 

  35. Mathew NT, Saper JR, Silberstein SD, et al.: Migraine prophylaxis with divalproex. Arch Neurol 1995, 52:281–286.

    PubMed  CAS  Google Scholar 

  36. Freitag FG, Diamond S, Diamond M, et al.: Divalproex in the long-term treatment of chronic daily headache. Headache 2001, 41:271–278.

    Article  PubMed  CAS  Google Scholar 

  37. Spira PJ, Beran RG: Gabapentin in the prophylaxis of chronic daily headache. A randomized, placebo-controlled study for the Australian Gabapentin Chronic Daily Headache Group. Neurology 2003, 61:1753–1759.

    PubMed  CAS  Google Scholar 

  38. Silberstein SD, Neto W, Schmitt J, et al.: Topiramate in the prevention of migraine headache: a randomized, double-blind, placebo-controlled, multiple-dose study. MIGR-001 Study Group. Arch Neurol 2004, 61:490–495.

    Article  PubMed  Google Scholar 

  39. Brandes JL, Saper JR, Diamond M, et al.: Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004, 291:965–973.

    Article  PubMed  CAS  Google Scholar 

  40. Mathew NT, Schmit TJ, Jacobs D, et al.: Topiramate in migraine prevention (MIGR-001): effect on migraine frequency [abstract]. Neurology 2003, 60:A336.

    Google Scholar 

  41. Silberstein S, Lipton RB, Dodick DW, et al.: Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007, 47:170–180.

    Article  PubMed  Google Scholar 

  42. Saper JR, Lake AE III, Cantrell DT, et al.: Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 2002, 42:470–482.

    Article  PubMed  Google Scholar 

  43. Mauskop A: Botulinum toxin in the treatment of chronic daily headache [abstract]. Cephalalgia 1999, 19:453.

    Article  Google Scholar 

  44. Dodick DW, Mauskop A, Elkind AH, et al.: Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized, double-blind, placebo-controlled study. Headache 2005, 45:315–324.

    Article  PubMed  Google Scholar 

  45. Silberstein SD, Stark SR, Lucas SM, et al.: Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2005, 80:1126–1137.

    Article  PubMed  CAS  Google Scholar 

  46. Saper JR, Lake AE III, Hamel RL, et al.: Daily scheduled opioids for intractable head pain: long-term observations of a treatment program. Neurology 2004, 62:1687–1694.

    PubMed  CAS  Google Scholar 

  47. Saper JR, Lake AE, Madden SF, et al.: Comprehensive/tertiary care for headache: a 6-month outcome study. Headache 1999, 39:249–263.

    Article  PubMed  CAS  Google Scholar 

  48. Freitag FG, Lake AE III, Lipton R, et al.: Inpatient treatment of headache: an evidence-based assessment. Headache 2004, 44:342–360.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Michigan Head Pain & Neurological Institute, 3120 Professional Drive, Ann Arbor, MI, 48104, USA

    Joel R. Saper

Authors
  1. Joel R. Saper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joel R. Saper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saper, J.R. Chronic daily headache: Transformational migraine, chronic migraine, and related disorders. Curr Neurol Neurosci Rep 8, 100–107 (2008). https://doi.org/10.1007/s11910-008-0017-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-008-0017-y

Keywords

Search

Navigation